Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

If the Paradigm Veo is used with Medtronic’s Enlite CGM sensors, Low Glucose Suspend means that, if you glucose levels become too low, the pump will automatically cease insulin delivery until your ...

Medtronic has recalled certain MiniMed 600 Series insulin pumps for delivering incorrect insulin dosing due to a missing or broken retainer ring, which helps lock the insulin cartridge in place in ...

生产商美敦力泌力美公司Medtronic MiniMed对胰岛素注射泵Insulin Pump（注册证号：国械注进20173141951）主动召回。 召回级别为一级。

生产商美敦力泌力美公司Medtronic MiniMed对胰岛素注射泵Insulin Pump（注册证号：国械注进20173141951）主动召回。 召回级别为一级。

The standout advance that the Medtronic MiniMed Paradigm Veo has brought is its Low Glucose Suspend feature. If the Paradigm Veo is used with Medtronic’s Enlite CGM sensors, Low Glucose Suspend means ...

Medtronic recently introduced the Paradigm 712 insulin pump system, which has the same user-friendly features as the Paradigm 512 insulin pump. The new Paradigm 712 pump holds a larger three ...

Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...

Medical device maker Medtronic has expanded its recall of remote controllers for its MiniMed 508 and MiniMed Paradigm insulin pumps. The reason? The devices are a potential cybersecurity risk.

Medtronic's Adapt trial put the algorithm-equipped MiniMed 780G insulin pump to the test against one standard of care for Type 1 diabetes.

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.